Michael Curran

16PUBLICATIONS
194CO-AUTHORS
Molecular medicineGene and molecular therapyImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 14, 2026
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody.

Ahmad Salameh, Elisabetta Bolli, Manuela Iezzi

|Feb 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.

Mark W Youngblood, Shashwat Tripathi, Hinda Najem

|Oct 30, 2024
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma.

Ricardo DeAzevedo, Madeline Steiner, Broderick X Turner

|Aug 15, 2024
LIFR regulates cholesterol-driven bidirectional hepatocyte-neutrophil cross-talk to promote liver regeneration.

Yalan Deng, Zilong Zhao, Marisela Sheldon

Pageof 3